ClinicalTrials.gov record
Completed Phase 2 Interventional

Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma

ClinicalTrials.gov ID: NCT00145639

Public ClinicalTrials.gov record NCT00145639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 11:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Osteosarcoma 1999-A Study Of Intensive Chemotherapy Utilizing Ifosfamide, Carboplatin, and Doxorubicin for Adjuvant Chemotherapy for Treatment of Osteosarcoma

Study identification

NCT ID
NCT00145639
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
St. Jude Children's Research Hospital
Other
Enrollment
80 participants

Conditions and interventions

Conditions

Interventions

  • Ifosfamide, Carboplatin, Doxorubicin Drug
  • Limb Sparing Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
Up to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 1999
Primary completion
Apr 30, 2006
Completion
Apr 30, 2006
Last update posted
Jun 9, 2011

1999 – 2006

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Washington University Medical Center St Louis Missouri 63110
St.Jude Children's Research Hospital Memphis Tennessee 38105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00145639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2011 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00145639 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →